AstraZeneca investors will look past another strong set of quarterly results on Thursday to focus on the main issue ...
Good morning, and welcome to Aramark's first quarter fiscal 2025 earnings results conference call. My name is Tanya, and I will be your operator for today's call. At this time, I would like to inform ...